A termék adatai:
| ISBN13: | 9780323960564 |
| ISBN10: | 0323960561 |
| Kötéstípus: | Keménykötés |
| Terjedelem: | 240 oldal |
| Méret: | 228x152 mm |
| Súly: | 450 g |
| Nyelv: | angol |
| 544 |
Témakör:
Update on Non-Alcoholic Steatohepatitis, An Issue of Clinics in Liver Disease
Sorozatcím:
The Clinics: Internal Medicine;
27-2;
Kiadó: Elsevier
Megjelenés dátuma: 2023. április 12.
Normál ár:
Kiadói listaár:
EUR 86.99
EUR 86.99
Az Ön ára:
29 666 (28 254 Ft + 5% áfa )
Kedvezmény(ek): 20% (kb. 7 417 Ft)
A kedvezmény érvényes eddig: 2024. december 31.
A kedvezmény csak az 'Értesítés a kedvenc témákról' hírlevelünk címzettjeinek rendeléseire érvényes.
Kattintson ide a feliratkozáshoz
Kattintson ide a feliratkozáshoz
Beszerezhetőség:
Megrendelésre a kiadó utánnyomja a könyvet. Rendelhető, de a szokásosnál kicsit lassabban érkezik meg.
Nem tudnak pontosabbat?
Hosszú leírás:
In this issue, guest editors bring their considerable expertise to this important topic.
-
Contains 20 practice-oriented topics, including metabolic syndrome associated with NASH; genetic markers and comorbidities predisposing to NASH and progressive liver disease; the role of bariatric surgery and endobariatric surgery in NASH; future treatment options and regimens for NAFLD; and more.
-
Provides in-depth clinical reviews on non-alcoholic steatohepatitis, offering actionable insights for clinical practice.
-
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Tartalomjegyzék:
Nonalcoholic Fatty Liver Disease: Disease Burden and Disease Awareness
Metabolic Syndrome and Its Association with Nonalcoholic Steatohepatitis
Hepatic Outcomes of Nonalcoholic Fatty Liver Disease Including Cirrhosis and Hepatocellular Carcinoma
Changings and Challenges in Liver Transplantation for Nonalcoholic Fatty Liver Disease/Steatohepatitis
Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease: Cardiovascular Diseases
Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease: Nonhepatocellular Cancers
Update on Nonalcoholic Steatohepatitis: Sarcopenia and Nonalcoholic Fatty Liver Disease
Nonalcoholic Fatty Liver Disease in Asia, Africa, and Middle East Region
Nonalcoholic Fatty Liver Disease in Latin America and Australia
Pathogenetic Pathways in Nonalcoholic Fatty Liver Disease: An Incomplete Jigsaw Puzzle
Genetic Markers Predisposing to Nonalcoholic Steatohepatitis
Role of Liver Biopsy in Clinical Trials and Clinical Management of Nonalcoholic Fatty Liver Disease
Roles of Radiological Tests in Clinical Trials and the Clinical Management of Nonalcoholic Fatty Liver Disease
Noninvasive Tests Used in Risk Stratification of Patients with Nonalcoholic Fatty Liver Disease
Current Treatment Options, Including Diet, Exercise, and Medications: The Impact on Histology
The Role Bariatric Surgery and Endobariatric Therapies in Nonalcoholic Steatohepatitis
Future Treatment Options and Regimens for Nonalcoholic Fatty Liver Disease
Special Population: Lean Nonalcoholic Fatty Liver Disease
Special Population: Pediatric Nonalcoholic Fatty Liver Disease
Economic Burden and Patient-Reported Outcomes of Nonalcoholic Fatty Liver Disease
Physicians' Use of Digital Health Interventions in the Management of Nonalcoholic fatty liver disease
Research Priorities for Precision Medicine in Nonalcoholic fatty liver disease
Metabolic Syndrome and Its Association with Nonalcoholic Steatohepatitis
Hepatic Outcomes of Nonalcoholic Fatty Liver Disease Including Cirrhosis and Hepatocellular Carcinoma
Changings and Challenges in Liver Transplantation for Nonalcoholic Fatty Liver Disease/Steatohepatitis
Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease: Cardiovascular Diseases
Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease: Nonhepatocellular Cancers
Update on Nonalcoholic Steatohepatitis: Sarcopenia and Nonalcoholic Fatty Liver Disease
Nonalcoholic Fatty Liver Disease in Asia, Africa, and Middle East Region
Nonalcoholic Fatty Liver Disease in Latin America and Australia
Pathogenetic Pathways in Nonalcoholic Fatty Liver Disease: An Incomplete Jigsaw Puzzle
Genetic Markers Predisposing to Nonalcoholic Steatohepatitis
Role of Liver Biopsy in Clinical Trials and Clinical Management of Nonalcoholic Fatty Liver Disease
Roles of Radiological Tests in Clinical Trials and the Clinical Management of Nonalcoholic Fatty Liver Disease
Noninvasive Tests Used in Risk Stratification of Patients with Nonalcoholic Fatty Liver Disease
Current Treatment Options, Including Diet, Exercise, and Medications: The Impact on Histology
The Role Bariatric Surgery and Endobariatric Therapies in Nonalcoholic Steatohepatitis
Future Treatment Options and Regimens for Nonalcoholic Fatty Liver Disease
Special Population: Lean Nonalcoholic Fatty Liver Disease
Special Population: Pediatric Nonalcoholic Fatty Liver Disease
Economic Burden and Patient-Reported Outcomes of Nonalcoholic Fatty Liver Disease
Physicians' Use of Digital Health Interventions in the Management of Nonalcoholic fatty liver disease
Research Priorities for Precision Medicine in Nonalcoholic fatty liver disease